BINEX Co., Ltd.
KOE: 053030.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Won-Seok Kim
- Employees
- 553
- Headquarters
- Incheon, South Korea
- IPO year
- 2001
- Market cap
- ₩336.3B
- Website
- https://www.bi-nex.co.kr
Loading 053030…
Loading profile data…Frequently asked questions about 053030
What does BINEX Co., Ltd. (053030.KQ) do?
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and...
Where does 053030.KQ trade?
BINEX Co., Ltd. (053030.KQ) trades on the KOSDAQ.
What sector is 053030.KQ in?
BINEX Co., Ltd. (053030.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BINEX Co., Ltd.?
Won-Seok Kim is the chief executive officer of BINEX Co., Ltd. (053030.KQ).
Where is BINEX Co., Ltd. headquartered?
BINEX Co., Ltd. is headquartered in South Korea.
Does 053030.KQ pay a dividend?
BINEX Co., Ltd. (053030.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 053030.KQ go public?
BINEX Co., Ltd. (053030.KQ) completed its initial public offering in 2001.